About Cohesive Technologies
Cohesive Technologies is a company based in Franklin (United States) founded in 1991 was acquired by Thermo Fisher Scientific in December 2006. Cohesive Technologies has raised $23.1 million across 2 funding rounds from investors including Thermo Fisher Scientific, Psilos Group and Hudson Ventures. Cohesive Technologies offers products and services including Transcend TurboFlow Systems and Multichannel Liquid Chromatography. Cohesive Technologies operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Franklin, United States
- SectorsHealthcare
- Email••••••••
- Website cohesivetech.com
- Acquired by Thermo Fisher Scientific (Dec 2006)
- Total Equity Funding$23.1M (USD)
in 2 rounds
- Latest Funding Round$9.5M (USD), Series B
Jun 2003
- InvestorsThermo Fisher Scientific
& 5 more
- Acquired byThermo Fisher Scientific
(Dec 2006)
Products & Services of Cohesive Technologies
Cohesive Technologies offers a comprehensive portfolio of products and services, including Transcend TurboFlow Systems and Multichannel Liquid Chromatography.
Automates cleanup of complex matrices for faster LC-MS analysis
Increases throughput for efficient LC-MS/MS clinical analysis
Funding Insights of Cohesive Technologies
Cohesive Technologies has successfully raised a total of $23.1M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $9.5 million completed in June 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $23.1M
- Total Rounds 2
- Last Round Series B — $9.5M
- First Round $13.6M
(Aug 2000)
- Investors Count 5
All 2 funding rounds of Cohesive Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2003 | $9.5M | Series B | – | Psilos Group | |
| Aug 2000 | $13.6M | Series A | – | – |
6 investors in total: 6 institutional.
Investors in Cohesive Technologies
Cohesive Technologies has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Thermo Fisher Scientific, Psilos Group and Hudson Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth-stage investments focused on US tech and life sciences. | – | psilos.com | New York, United States | |
Early-stage tech and life sciences focused VC investment company funding companies in the US | – | hudsonventures.com | New York, United States | |
Venture capital is invested in AI, energy, and various sectors. | – | mucap.co.jp | Tokyo, Japan | |
Early stage VC firm investing in the US and Korea | – | oxbio.com | Boston, United States | |
United Paper Box Co. is engaged in premium packaging solutions. | 1979 | uni-pac.com | Holyoke, United States | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | thermofisher.com | Waltham, United States |
Investor details for Cohesive Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cohesive Technologies
1 people are tracked at Cohesive Technologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
Marc Casper | CEO & President | Leadership |
Complete people profiles for Cohesive Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cohesive Technologies
4 dated milestones of Cohesive Technologies across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Cohesive Technologies is founded.
- Funding First funding round of $13.6M.
- Funding Latest funding round, Series B, of $9.5M.
- Exit Acquired by Thermo Fisher Scientific.
Competitors of Cohesive Technologies
Cohesive Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| lifeminetx.com | 2016 | Cambridge, United States | $300.07M | 85 | Developer of novel drugs from fungi via genome mining and recombinant overexpression |
Detailed competitors of Cohesive Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cohesive Technologies
Websites that share an audience with Cohesive Technologies (cohesivetech.com).
Websites whose visitors overlap most with Cohesive Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cecilinstruments.com | 100% | – | – | View details | |
dosierpumpen.net | dosierpumpen.net | 98% | – | – | – |
ecomsro.com | ecomsro.com | 98% | – | #3,070,343 | – |
iconsci.com | iconsci.com | 88% | – | #6,035,376 | – |
| dionex.com | 88% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for Cohesive Technologies
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Similar companies to Cohesive Technologies
10 companies that operate in the same segment as Cohesive Technologies (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cohesive Technologies
Cohesive Technologies was founded in 1991 and raised its 1st funding round 9 years after it was founded.
Cohesive Technologies is headquartered in Franklin, United States.
Marc Casper is the current CEO of Cohesive Technologies.
Cohesive Technologies is a funded company, having raised a total of $23.1M across 2 funding rounds to date. The company's 1st funding round was a Series A of $13.6M, raised on Aug 2000.
Cohesive Technologies was founded in 1991 in Franklin, United States, within the biotechnology sector. Bio-resorbable devices, adhesive technologies, and delivery systems for tissue repair and regeneration are developed and commercialized. Liquid chromatography solutions are supplied to the drug discovery, pharmaceutical, contract research, and clinical diagnostic industries. Acquisition by ThermoFisher occurred in 2007 for an undisclosed amount.
Cohesive Technologies's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Cohesive Technologies offers Transcend TurboFlow Systems and Multichannel Liquid Chromatography.
Cohesive Technologies has 6 investors. Key investors include Thermo Fisher Scientific, Psilos Group, Hudson Ventures, Mitsubishi UFJ Capital, and Oxford Bioscience Partners.
Yes. Cohesive Technologies was acquired by Thermo Fisher Scientific in December 2006.